GPT and metabolic dysfunction-associated steatotic liver disease: Elevated ALT may reflect early stages of metabolic dysfunction-associated steatotic liver disease (MASLD), which is increasingly recognized as a hepatic manifestation of pediatric metabolic syndrome [13].